Friday, November 16, 2018

FDA approves new drug to treat travelers’ diarrhea - FDA Press Releases

FDA approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

from Food and Drug Administration--Press Releases https://ift.tt/2QJuCot
via IFTTT

No comments:

Post a Comment